Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Nardin

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Cardiovascular Drugs and Therapy|October 3, 2015
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet TherapyMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 2, 2021
Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelorMonica Verdoia, Roberta Rolla, Patrizia Pergolini, et al.
Expert Opinion on Pharmacotherapy|June 13, 2015
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelorMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Thrombosis Research|September 11, 2020
Impact of the rs73598374 polymorphism of the adenosine deaminase gene on platelet reactivity and long-term outcomes among patients with acute coronary syndrome treated with ticagrelorMonica Verdoia, Francesco Tonon, Rocco Gioscia, et al.
The Clinical Respiratory Journal|August 6, 2017
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjectsMario Malerba, Alessandro Radaeli, Matteo Nardin, et al.
Thrombosis Research|May 15, 2016
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patientsMatteo Nardin, Monica Verdoia, Chiara Sartori, et al.
Atherosclerosis|November 2, 2015
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapyMonica Verdoia, Matteo Nardin, Chiara Sartori, et al.
Cardiovascular Drugs and Therapy|February 13, 2016
Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet TherapyMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Cardiovascular Therapeutics|April 18, 2016
Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or TicagrelorMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Metabolism: Clinical and Experimental|March 11, 2014
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort studyMonica Verdoia, Lucia Barbieri, Alon Schaffer, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Cardiovascular Drugs and Therapy|October 3, 2015
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet TherapyMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 2, 2021
Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelorMonica Verdoia, Roberta Rolla, Patrizia Pergolini, et al.
Expert Opinion on Pharmacotherapy|June 13, 2015
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelorMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Thrombosis Research|September 11, 2020
Impact of the rs73598374 polymorphism of the adenosine deaminase gene on platelet reactivity and long-term outcomes among patients with acute coronary syndrome treated with ticagrelorMonica Verdoia, Francesco Tonon, Rocco Gioscia, et al.
The Clinical Respiratory Journal|August 6, 2017
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjectsMario Malerba, Alessandro Radaeli, Matteo Nardin, et al.
Thrombosis Research|May 15, 2016
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patientsMatteo Nardin, Monica Verdoia, Chiara Sartori, et al.
Atherosclerosis|November 2, 2015
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapyMonica Verdoia, Matteo Nardin, Chiara Sartori, et al.
Cardiovascular Drugs and Therapy|February 13, 2016
Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet TherapyMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Cardiovascular Therapeutics|April 18, 2016
Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or TicagrelorMonica Verdoia, Patrizia Pergolini, Roberta Rolla, et al.
Metabolism: Clinical and Experimental|March 11, 2014
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort studyMonica Verdoia, Lucia Barbieri, Alon Schaffer, et al.
Pageof 13